Background and Purpose-White matter hyperintensities (WMH) are frequently seen on neuroimaging of elderly and are associated with cognitive decline and the development of dementia. Yet, the temporal dynamics of conversion of normalappearing white matter (NAWM) into WMH remains unknown. We examined whether and when progression of WMH was preceded by changes in fluid-attenuated inversion recovery and diffusion tensor imaging values, thereby taking into account differences between participants with mild versus severe baseline WMH.
W hite matter hyperintensities (WMH) are part of the spectrum of cerebral small vessel disease (SVD) markers and are frequently observed on magnetic resonance imaging (MRI) scans in individuals >60 years of age. [1] [2] [3] WMH are associated with cognitive decline and the development of dementia. 4, 5 The pathophysiology of WMH remains poorly understood, in part, because studies on WMH and its progression have mainly used conventional MRI, thereby unable to assess its earlier stages that perhaps were not yet visible. Imaging techniques, such as diffusion tensor imaging (DTI), can possibly provide additional information on these earlier stages by the assessment of the microstructural organization of the white matter (WM). [6] [7] [8] [9] Previous longitudinal studies have shown changes in baseline DTI parameters, that is, decreased fractional anisotropy (FA) and increased mean diffusivity (MD), that predicted incident WMH at follow-up. over time. 12 Besides, progression was found most pronounced in participants with severe WMH, 12, 13 suggesting differences in pathogenesis for mild versus severe WMH. More knowledge of the sequence of events that precedes the conversion of NAWM toward WMH might result in better identification of patients at risk for further WMH progression and the attendant clinical symptoms. This would especially be useful to identify in which individuals and at what moment preventive therapies could be beneficial.
In the present study, we, therefore, examined whether and when progression of WMH was preceded by changes in fluid-attenuated inversion recovery (FLAIR) and DTI values, using neuroimaging assessments at 3 time points for 9 years in 266 participants with SVD. We also studied differences between those with mild versus severe WMH. Finally, we analyzed the degree of WMH progression during follow-up according to baseline FLAIR and DTI measures.
Materials and Methods

Study Population
The RUN DMC study (Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Imaging Cohort) is a prospective cohort study of elderly with SVD that investigates risk factors and clinical consequences of SVD. The detailed study protocol has been published previously.
14 Of 503 baseline participants, 281 participants underwent repeated neuroimaging assessments at 3 time points (baseline in 2006, first follow-up in 2011, and second follow-up in 2015). 12 Fifteen participants were additionally excluded because of insufficient scan quality, yielding 266 participants for the present study. The Medical Review Ethics Committee region Arnhem-Nijmegen approved the study, and all participants gave written informed consent. The data that support the findings of this study are available from the corresponding author on request.
Vascular Risk Factors
We assessed the presence of hypertension, smoking, alcohol use, diabetes mellitus, and hypercholesterolemia at baseline by standardized questionnaires, as described previously. 14 We defined hypertension as use of antihypertensive agents and systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg. . Full acquisition details have been described previously.
12,14
Brain Tissue Segmentation and Volumetry
We calculated gray matter, WM, and cerebrospinal fluid volumes using SPM12 (http://www.fil.ion.ucl.ac.uk/spm/) unified segmentation routines on the T1 magnetization-prepared rapid gradient-echo images. 12 Next, we created binary WM masks from the WM segmentation maps. WMH were segmented semiautomatically using FLAIR and T1 sequences. 15 All segmentations were visually checked for artifacts and segmentation errors, blinded for clinical data. WMH volumes were calculated in milliliters, corrected for interscan differences in intracranial volume, and normalized to baseline intracranial volume.
DTI Processing
All diffusion-weighted images were denoised using a local principal component analyses filter 16 and corrected for cardiac, head motion, and eddy current artifacts simultaneously using the patching artefacts from cardiac and head motion (PATCH) algorithm, 17 as described previously. 18 Diffusion tensor and scalar parameters were calculated using DTIFit from FMRIB's Diffusion Toolbox (FDT), part of FMRIB Software Library (FSL).
Spatial Normalization
The spatial normalization process is described in the online-only Data Supplement, and a schematic overview of the spatial normalization process is displayed in Figure I in the online-only Data Supplement.
Normalization of FLAIR Values
To account for interindividual differences in FLAIR intensities, we normalized the FLAIR values. 11 We calculated the mean (μFLAIR) and SD (σFLAIR) of FLAIR values in the NAWM for each participant and defined a z score per voxel (z score
The same procedure was applied to follow-up FLAIR images.
Definition of Regions
We created 4 masks for each participant: (1) 
Statistical Analysis
We used t tests to compare mean baseline FLAIR, FA, and MD values in (1) remaining NAWM with values in (2) NAWM voxels converting into WMH in the second follow-up period, (3) NAWM converting into WMH in the first follow-up period, and (4) 19 to evaluate whether changes in microstructural integrity preceding WMH progression differed between participants with mild versus severe baseline WMH. We used 1-way ANOVA to investigate whether baseline FLAIR and DTI values in the previously mentioned 4 areas differed between participants with mild versus severe WMH. Additionally, we used repeated-measures ANOVA to investigate changes in MD values over time in the 4 areas. To investigate associations between baseline MD and FLAIR values and severity of WMH progression, we calculated quintiles of baseline MD and FLAIR values and analyzed WMH progression according to these strata, by 1-way ANOVA adjusted for age and sex, followed by a Bonferroni correction, and tested continuous linear trend per stratum. Statistical analyses were performed using Matlab, version 2014b, and SPSS Statistics, version 20.
Results
Baseline characteristics of the study population are presented in the Table. Mean age at baseline was 62.5 (SD, 7.8) years. Mean follow-up duration until first follow-up assessment was 5.4 (SD, 0.2) years and 8.7 (SD, 0.2) years until second follow-up assessment. Median WMH volume progressed from 2.2 mL (interquartile range, 0.8-6.1 mL) at baseline to 2.8 mL (interquartile range, 1.2-7.5 mL) at first follow-up and to 4.7 mL (interquartile range, 2.0-11.5 mL) at second follow-up. We observed lacunes in 52 participants (19.5%) at baseline and incident lacunes in 20.3% of participants. Presence of lacunes was more frequent in participants with severe WMH compared with participants with mild WMH (49.1% versus 11.8%; P<0.001). Participants who had not completed follow-up assessment were significantly older at baseline, had more vascular risk factors, and had more severe SVD characteristics (Table I in 
Changes in MD Values Over Time
In Figure 
WMH Progression According to Baseline FLAIR and DTI Parameters
We evaluated the progression of WMH at different levels of baseline FLAIR and DTI parameters by dividing the groups into quintiles. Figure 4 . Higher baseline MD values in NAWM were associated with increased WMH progression during 9 years (mean difference, highest versus lowest quintile: 0.73 mL/y; 95% confidence interval, 0.26-1.19; P<0.001 adjusted for age and sex; overall P trend, <0.001). Higher FLAIR values at baseline were also associated with increased progression of WMH (mean difference, highest versus lowest quintile: 0.47 mL/y; 95% confidence interval, 0.03-0.91; P=0.025; overall P trend, <0.001).
Discussion
In this longitudinal study with 3 imaging assessments during 9 years, we observed that impaired microstructural integrity in the NAWM preceded conversion into WMH and that WM microstructural integrity declined over time. Participants with severe baseline WMH showed more loss of structural integrity compared with participants with mild WMH in all areas of the WM, including the remaining NAWM. These results suggest that WMH progression is an ongoing process characterized by loss of WM microstructural integrity occurring years before WMH can be detected on conventional MRI.
These results are in line with 2 longitudinal studies showing changes in baseline DTI and FLAIR signal intensities that were related to incident WMH at follow-up, with mean follow-up duration of 3.5 and 3.7 years. 10, 11 Here, we extended these findings by adding an additional time point with a total follow-up of 9 years, which enabled us to distinguish between NAWM converting into WMH within the first and the second time period. We observed that baseline MD values were higher in NAWM areas converting into WMH within 5 years than in NAWM areas that converted into WMH between 5 and 9 years. Besides, MD values continued to increase over time. The continuously ongoing decline of microstructural integrity within the WM underlines that WMH progression visible on conventional FLAIR imaging is only the tip of the iceberg with underlying loss of microstructural integrity that can only be visualized using more advanced neuroimaging techniques.
Participants with severe baseline WMH showed higher normalized FLAIR and MD values and lower FA values than participants with mild baseline WMH in all areas, including the remaining NAWM. Differences between participants with mild versus severe baseline WMH have been reported before with respect to progression of their WMH, suggesting heterogeneity in pathogenesis of mild versus severe WMH. 12, 13, 20 Our observed differences in microstructural integrity between participants with mild and severe baseline WMH in both remaining NAWM and WMH confirm and extend this hypothesis. The observation of impaired microstructural integrity in remaining NAWM in participants with baseline Fazekas 2 to 3 indicates that NAWM is not as normal as one would expect from conventional MRI and underlines the hypothesis of a continuous, ongoing disease of the WM in SVD. Moreover, it might be an explanation for the observation that WMH progression was most pronounced in participants with severe WMH at baseline. 12 The findings that the microstructural integrity within WMH was more impaired in participants with severe baseline WMH than in participants with mild baseline WMH and also continuously declined over time within WMH in both groups suggest that not only NAWM but also WMH is heterogeneous. This heterogeneity of microstructural integrity in WMH might explain clinical variances observed in subjects with similar SVD severity. For example, participants with impaired WMH microstructural integrity might have more severe clinical symptoms compared with participants with the same degree of WMH but with higher microstructural integrity in their WMH. This hypothesis is supported by findings in patients with SVD, showing that patients with severe loss of microstructural integrity within their WMH showed decreased cognitive performance and had higher risk of Parkinsonian signs, independent of WMH volume. 21, 22 Our findings can be clinically relevant because differences in microstructural integrity between remaining NAWM and incident WMH suggest that it would be possible to predict which NAWM voxels will convert into WMH, based on baseline FLAIR and DTI values. Our observation that impaired microstructural integrity at baseline was associated with more extensive WMH progression during 9 years implies that measures of microstructural integrity can possibly be used as biomarker for WMH progression, as well as for personalized treatment approaches. Increasing evidence suggests that endothelial dysfunction might be an important factor in the pathogenesis of SVD because loss of WM microstructure has been associated with reduced endothelial function. 23 Although speculative, potential treatment strategies might target the brains' microvascular endothelium with endothelin antagonists or NO donors, 24 although randomized controlled trials are required. For now, we would argue a stringent control of vascular risk factors according to current guidelines, until further data from randomized controlled trials are available.
Major strengths of this study include the longitudinal design of our study with 3 neuroimaging assessments during 9 years, which enabled us to elaborate on the temporal dynamics of WMH progression. Furthermore, the availability of these 3 time points enabled us to validate the findings in the other follow-up periods.
Several methodological issues and limitations deserve consideration. First, differences in MRI scanner and FLAIR sequences between baseline and first follow-up might be a potential source of bias because this might have led to differences in coregistrations of the FLAIR images and WMH masks to Montreal Neurological Institute space between baseline and first and second follow-up images. However, we consider this unlikely because we performed several analyses to estimate and minimize the effects of possible interscan effects. Coregistrations of all images to Montreal Neurological Institute space have been performed with great caution using an intermediate subject template and the most robust and accurate registration routines. 25 Besides, in additional analyses, we only used those WMH voxels that were classified as WMH both at baseline and at follow-up imaging, reducing the risk of bias because of possible overestimation of WMH at baseline. These analyses revealed similar results (data not shown). Moreover, we validated our findings by repeating analyses for all time periods separately (Table II in the online-only Data Supplement). The results for the first follow-up and the overall time interval were comparable with the results for the second follow-up period in which scanner and sequence protocols remained identical. Hence, it is unlikely that change in scanner between baseline and first follow-up biased the results. Second, so-called partial volume effects might have introduced a potential bias, that is, NAWM voxels around the border of existing WMH can contain a fraction of WMH signal intensity that affects measurements in that voxel. It is possible that this has led to an overestimation of intensities in the masks consisting of NAWM voxels that converted into WMH during follow-up when WMH progression occurred adjacent to already existing WMH. However, it cannot explain all differences, especially also because NAWM voxels remote from preexisting WMH were included in the masks. Third, because of the long-term follow-up of our study, a proportion of the participants was unable to complete the entire follow-up. This attrition bias might have led to an underestimation of the effects because those lost to follow-up had more severe SVD already at baseline (Table I in the online-only Data Supplement), and severity of WMH at baseline is associated with progression of WMH. 12, 13, 20 A fourth limitation might be that we would need even more advanced neuroimaging protocols to visualize the underlying mechanisms of final conversion of NAWM into WMH because MD values in NAWM that converted into WMH within 5 years were similar to MD values in WMH. Otherwise, it might be that other processes, such as secondary neurodegeneration, hypoperfusion, inflammation, or small acute infarctions, play a role in the final conversion into WMH. Studies with more follow-up ascertainments on shorter time intervals may shed more light on the underlying processes of the final conversion into WMH. Because there is increasing awareness that SVD exerts its clinical effects by affecting remote brain structures, [26] [27] [28] [29] future studies should also address the role of gray matter atrophy and how it is affected by WMH progression. In addition, it would be of interest to study changes in microstructural integrity preceding incident lacunes because the presence of lacunes plays an important role in the development of cognitive deficits as well. 30, 31 In conclusion, WMH progression visible on conventional FLAIR imaging is only the tip of the iceberg with underlying loss of WM microstructural integrity that continuously declines over time. These findings indicate that microstructural measures derived from DTI can predict the development of WMH years before they are visible on conventional neuroimaging. Future studies should elaborate on the possibility to use these measures of microstructural integrity for personalized treatment approaches.
